Table 1 Study Population Characteristics
Age (yrs) | 58.6 ± 18 |
Gender (M/F) | 13/1 |
BMI (g/m2) | 23.8 ± 2.6 |
Diabetes (Y/N) | 5/9 |
Known CAD (Y/N) | 5/9 |
Aetiology of ESRF (DM/HTN/Other) | 5/3/6 |
ACEi/ARB (Y/N) | 5/9 |
Calcium channel blocker (Y/N) | 10/4 |
Beta blocker (Y/N) | 10/4 |
Alpha blocker (Y/N) | 2/12 |
Diuretic (Y/N) | 6/8 |
Use of ESA (Y/N) | 10/4 |
Time on dialysis (months) | 9 (4–172) |
Time receiving HD (months) | 6 (1–172) |
Previous transplant (Y/N) | 4/10 |
Current HD access (CVC/AVF) | 12/2 |
Hemoglobin (g/L) | 107 ± 13 |
Haematocrit (L/L) | 0.324 ± 0.04 |
Sodium (mmol/L) | 136 ± 3.9 |
Albumin (g/L) | 38.5 ± 6.2 |
Bilirubin (μmol/L) | 4.19 ± 1.2 |